[Extracorporeal immunosorption in the treatment of atopic bronchial asthma].
The author presents information on the use and clinical efficacy of extracorporeal therapeutic methods in various diseases. The main difficulties in the assessment of the efficacy of these therapeutic methods have been unraveled. The results of the use of immunosorption in systemic lupus erythematosus, cancer, hemophilia, diabetes mellitus, ABO-incompatibility and bronchial asthma indicate the promise of this approach to the performance of specific therapeutic programs.
D000485:Allergens / Q000276:immunology; D001249:Asthma / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D003888:Desensitization, Immunologic / Q000379:methods*; D004391:Dust / Q000009:adverse effects; D006464:Hemoperfusion / Q000379:methods*; D006801:Humans; D007105:Immune Complex Diseases / Q000628:therapy*; D007163:Immunosorbent Techniques; D007164:Immunosorbents / Q000276:immunology; D011058:Pollen / Q000276:immunology
D000485:Allergens; D004391:Dust; D007164:Immunosorbents
Ekstracorporal'naia immunosorbtsiia v lechenii atopicheskoĭ astmy.